The transaction is led by TT Venture, a fund currently in liquidation, which was one of the first to support the scale-up's development
The new fund will remain operational until 30 June 2029 and will invest in companies based in Lombardy operating in the life sciences and biotechnology sectors
Capital leverages Lombardy Region fund, scaleup develops active automotive solutions
Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.